查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1481833

全球薄膜藥物製造市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Thin Film Drug Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2032年，全球薄膜藥物製造市場的市場規模將從2023年的70.1億美元達到近168.4億美元，2024-2032年研究期間的複合年成長率為10.23%。

薄膜藥物製造涉及使用專門的製造程序和設備生產薄膜或包衣的藥物劑型。這些薄膜藥物遞送系統通常由含藥物的聚合物基質或塗層組成，它們在口腔或皮膚上快速溶解或崩解，從而能夠快速吸收並發揮治療作用。這些技術包括溶劑澆鑄、熱熔擠出、噴塗和印刷，能夠精確控制薄膜厚度、藥物含量和釋放動力學。它具有改善患者依從性、增強生物利用度和易於給藥等優點，使其適用於各種藥物傳遞途徑，包括口服、含服、舌下和經皮給藥。

市場動態

對可提高患者依從性、功效和便利性的創新藥物輸送系統的需求不斷成長，推動了薄膜技術的採用。薄膜藥物製造可以將藥物化合物精確沉積到軟性薄膜基材上，然後可以口服、舌下或經皮給藥，以實現快速、受控的藥物釋放。此技術使得新型劑型的開發成為可能，例如口服可溶膜、經皮貼片和黏膜黏附膜，與傳統口服劑型相比，其具有提高生物利用度、減少給藥頻率和改善掩味等優點。此外，薄膜製造流程（例如溶劑澆鑄、熱熔擠出和噴墨印刷）的多功能性和可擴展性，使得能夠高效生產針對特定患者需求和治療要求的客製化藥物配方和組合產品。此外，心血管疾病、糖尿病和神經退化性疾病等慢性疾病的流行，推動了對有針對性的個人化給藥解決方案的需求，以最佳化治療結果並最大限度地減少副作用。此外，配方科學、材料工程和藥物塗層的進步正在擴大薄膜藥物製造在各種治療領域的能力和應用，包括疼痛管理、荷爾蒙替代療法和戒菸。此外，學術機構、製藥公司和政府機構對研發的投資不斷增加，推動了薄膜藥物輸送系統的創新和技術進步。此外，支持薄膜產品開發和商業化的監管途徑和指南的出現，以及創新藥物配方的有利報銷政策，正在為市場成長創造有利的環境。然而，替代藥物傳輸技術和個人化醫療方法的發展可能會挑戰未來幾年薄膜藥物製造市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球薄膜藥物製造市場的每個細分市場進行了包容性評估。薄膜藥品製造業的成長和趨勢為本研究提供了整體方法。

市場區隔

薄膜藥品製造市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 口腔薄膜（舌下膜、全溶解牙科/頰膜）
  • 經皮薄膜
  • 其他（眼部薄膜等）

按疾病適應症

  • 精神分裂症
  • 偏頭痛
  • 鴉片類藥物依賴
  • 噁心，嘔吐
  • 其他

按配銷通路

  • 醫院藥房
  • 藥局
  • 零售藥局
  • 電子商務

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲薄膜藥物製造市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。薄膜藥物製造市場的主要參與者包括輝瑞公司、諾華、威科集團、索爾維、艾伯維、住友製藥有限公司、IntelGenx Corp.、NAL Pharma、ZIM Laboratories Limited、Indivior PLC、MonoSol。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：薄膜藥品製造 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 依疾病適應症進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球薄膜藥品製造市場分析：依產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 口腔薄膜（舌下膜、全溶解牙科/頰膜）
  • 經皮薄膜
  • 其他（眼部薄膜等）

第 6 章：全球薄膜藥品製造市場分析：依疾病適應症

  • 按疾病適應症概述
  • 歷史和預測數據
  • 按疾病指徵分析
  • 精神分裂症
  • 偏頭痛
  • 鴉片類藥物依賴
  • 噁心，嘔吐
  • 其他

第 7 章：全球薄膜藥品製造市場分析：按分銷管道

  • 配銷通路概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 藥局
  • 零售藥局
  • 電子商務

第 8 章：全球薄膜藥品製造市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：薄膜藥品製造公司的競爭格局

  • 薄膜藥物製造市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Pfizer Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novartis AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Wolters Kluwer
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Solvay
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AbbVie
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sumitomo Pharma Co. Ltd
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IntelGenx Corp.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • NAL Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • ZIM Laboratories Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Indivior PLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MonoSol
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114442

The global demand for Thin Film Drug Manufacturing Market is presumed to reach the market size of nearly USD 16.84 Billion by 2032 from USD 7.01 Billion in 2023 with a CAGR of 10.23% under the study period 2024-2032.

Thin film drug manufacturing involves the production of pharmaceutical dosage forms in thin films or coatings using specialized manufacturing processes and equipment. These thin film drug delivery systems typically consist of drug-containing polymer matrices or coatings that dissolve or disintegrate rapidly in the mouth or on the skin, allowing for quick absorption and onset of therapeutic effects. These technologies include solvent casting, hot melt extrusion, spray coating, and printing, which enable precise control over film thickness, drug content, and release kinetics. It offers advantages such as improved patient compliance, enhanced bioavailability, and ease of administration, making them suitable for various routes of drug delivery, including oral, buccal, sublingual, and transdermal administration.

MARKET DYNAMICS

Increasing demand for innovative drug delivery systems that offer improved patient compliance, efficacy, and convenience is fuelling the adoption of thin film technology. Thin film drug manufacturing allows for the precise deposition of pharmaceutical compounds onto a thin, flexible film substrate, which can then be administered orally, sublingually, or transdermally for rapid and controlled drug release. This technology enables the development of novel dosage forms, such as oral dissolvable films, transdermal patches, and mucoadhesive films, which offer advantages such as enhanced bioavailability, reduced dosing frequency, and improved taste masking compared to traditional oral dosage forms. Additionally, the versatility and scalability of thin film manufacturing processes, such as solvent casting, hot-melt extrusion, and inkjet printing, enable efficient production of customized drug formulations and combination products tailored to specific patient needs and therapeutic requirements. Moreover, the spurring prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and neurodegenerative conditions, is driving the demand for targeted and personalized drug delivery solutions that optimize treatment outcomes and minimize side effects. Furthermore, advancements in formulation science, materials engineering, and pharmaceutical coatings are expanding the capabilities and applications of thin film drug manufacturing in various therapeutic areas, including pain management, hormone replacement therapy, and smoking cessation. Additionally, the increasing investment in research and development by academic institutions, pharmaceutical companies, and government agencies drives innovation and technological advancements in thin film drug delivery systems. Furthermore, the emergence of regulatory pathways and guidelines supporting the development and commercialization of thin film products, along with favorable reimbursement policies for innovative drug formulations, are creating a conducive environment for market growth. However, developments in alternative drug delivery technologies and personalized medicine approaches may challenge the thin film drug manufacturing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Thin Film Drug Manufacturing. The growth and trends of Thin Film Drug Manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Thin Film Drug Manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film)
  • Transdermal Thin Film
  • Others (Ocular Thin Film, etc.)

By Disease Indication

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea & Vomiting
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • E-commerce

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Thin Film Drug Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Thin Film Drug Manufacturing market include Pfizer Inc., Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co. Ltd, IntelGenx Corp., NAL Pharma, ZIM Laboratories Limited, Indivior PLC, MonoSol. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. THIN FILM DRUG MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease Indication
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Historic and Forecast Sales By Regions
  • 5.5. Transdermal Thin Film Historic and Forecast Sales By Regions
  • 5.6. Others (Ocular Thin Film, etc.) Historic and Forecast Sales By Regions

6. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISEASE INDICATION

  • 6.1. Overview By Disease Indication
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Disease Indication
  • 6.4. Schizophrenia Historic and Forecast Sales By Regions
  • 6.5. Migraine Historic and Forecast Sales By Regions
  • 6.6. Opioid Dependence Historic and Forecast Sales By Regions
  • 6.7. Nausea & Vomiting Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Distribution Channel
  • 7.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Drug Stores Historic and Forecast Sales By Regions
  • 7.6. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.7. E-commerce Historic and Forecast Sales By Regions

8. GLOBAL THIN FILM DRUG MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE THIN FILM DRUG MANUFACTURING COMPANIES

  • 9.1. Thin Film Drug Manufacturing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF THIN FILM DRUG MANUFACTURING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Novartis AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Wolters Kluwer
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Solvay
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. AbbVie
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Sumitomo Pharma Co. Ltd
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. IntelGenx Corp.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. NAL Pharma
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. ZIM Laboratories Limited
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Indivior PLC
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. MonoSol
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Market Sales By Geography (USD MN)
  • Transdermal Thin Film Market Sales By Geography (USD MN)
  • Others (Ocular Thin Film, etc.) Market Sales By Geography (USD MN)
  • Analysis By Disease Indication (USD MN)
  • Schizophrenia Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • E-commerce Market Sales By Geography (USD MN)
  • Global Thin Film Drug Manufacturing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Thin Film Drug Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Thin Film Drug Manufacturing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease Indication
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Oral Thin Film (Sublingual Film, Fully Dissolving Dental/Buccal Film) Market Sales By Geography (USD MN)
  • Transdermal Thin Film Market Sales By Geography (USD MN)
  • Others (Ocular Thin Film, etc.) Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Indication (USD MN)
  • Schizophrenia Market Sales By Geography (USD MN)
  • Migraine Market Sales By Geography (USD MN)
  • Opioid Dependence Market Sales By Geography (USD MN)
  • Nausea & Vomiting Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Drug Stores Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • E-commerce Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.